CorVel Corp. Common Stock (CRVL) fair value

ACCE thesis

CorVel runs a national network of managed care services for workers' compensation and group health payers: bill review, utilization management, and case management, sold largely to self-insured employers and third-party administrators. Its moat is operational rather than brand: the company processes claims through proprietary software and a large network of nurse case managers, and its contracts are sticky because switching vendors mid-claim is costly for payers. Growth is running at 10.7% on revenue, and the business converts that into a 30.7% return on equity with a 16.7% operating margin, though the 24.8% gross margin leaves little cushion if pricing pressure returns. At a trailing P/E of 35.6 and a forward P/E of 23.8, the market is pricing in meaningful earnings growth from here, so the case rests on whether that growth arrives. A 4.0 billion dollar market cap with no index membership means the name is under-owned by passive money, which can matter for liquidity and for re-rating if it is added later. Score of 68 out of 100 suggests the quality profile is solid but not exceptional, so this earns a deeper look mainly for the return profile and the forward multiple compression, not as a screen-clearing bargain.